The NIHR Southampton Clinical Research Facility (CRF) is delivered in a longstanding partnership between the University and University Hospital Southampton NHS Foundation Trust.
There are several opportunities this month for staff and their families to take part in ground-breaking clinical research studies that will improve treatments and care.
Needleless COVID-19 vaccine
Professor Saul Faust is leading a first-in-human, needle-less vaccine study that is designed to protect against multiple coronavirus variants.
We are looking for people who are:
- aged 18-50 in good health
- immunised with 2 or 3 doses of COVID-19 vaccine
- able to attend up to 11 visits
- have not tested positive for COVID-19 in the last 180 days
Contact [email protected] for more information. Payment of up to £1,005 will be provided.
New treatments for COVID-19
Do you have COVID-19 symptoms that have started within the last 5 days?
You could be eligible to take part in the AGILE CST-8 trial, which is delivered by the university’s Southampton Clinical Trials Unit.
This would involve trialling new, promising treatments for COVID-19, and you would also be reimbursed £650 for your time and participation. Travel expenses may also be covered.
Visit the Agile trial website for more information.
Help us fight whooping cough
We are currently looking for healthy participants aged between 18 – 55 years to take part in a new whooping cough study.
The PERISCOPE C trial is led in Southampton by Professor Robert Read.
The study participation is up to 10 weeks and participants will be compensated up to £785 for their time and travel.
Contact [email protected] for more information.
